Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modeling prognosis for patients with malignant astrocytic gliomas: Quantifying the expression of multiple genetic markers and clinical variables

1 Oct 2005

Abstract excerpt

The disparate lengths of survival among patients with malignant astrocytic gliomas (anaplastic astrocytomas [AAs] and glioblastoma multiforme [GBM]) cannot be adequately accounted for by clinical variables (patient age, histology, and recurrent status). Using real-time quantitative reverse transcription-polymerase chain reaction, we quantified the expression of four genes that were putative prognostic markers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Glioma Diagnosis and Treatment
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16212813
DOI: 10.1215/s1152851704000730

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Modeling prognosis for patients with malignant astrocytic gliomas: Quantifying the expression of multiple genetic markers and clinical variablesPMID 16212813Read ↗

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.Semantic proximity Read ↗

Reverse Engineering of Modified Genes by Bayesian Network Analysis Defines Molecular Determinants Critical to the Development of GlioblastomaSemantic proximity Read ↗

Identification of Astrocytoma Blood Serum Protein ProfileSemantic proximity Read ↗

Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomasSemantic proximity Read ↗

Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signaturesSemantic proximity Read ↗

Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas.Semantic proximity Read ↗

Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in MedulloblastomasSemantic proximity Read ↗

IGFBP2 is a candidate biomarker for <i>Ink4a-Arf</i> status and a therapeutic target for high-grade gliomasSemantic proximity Read ↗

A Clinicobiological Model Predicting Survival in MedulloblastomaSemantic proximity Read ↗

Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.